Contact Us

ActiGraft^Pro® system is intended to be used at point-of-care for the safe and rapid preparation of a whole blood clot (WBC) from a small sample of a patient’s own peripheral blood. Under the supervision of a healthcare professional, the WBC produced by the ActiGraft^Pro® system is topically applied for the management of exuding cutaneous wounds such as leg ulcers, pressure ulcers, diabetic ulcers, and mechanically or surgically-debrided wounds.

Yes, the ActiGraft^Pro® whole blood clot can be cut to size with sterile scissors.

A minimum of 50% of the wound needs to be covered for a clinical response.

The choice of secondary dressing depends on the healthcare provider’s preference for exudate management. While a foam is included with the ActiGraft^Pro system, additional advanced wound management (AWM) dressings can be utilized to address specific local factors.

In the clinical studies performed, ActiGraft^Pro was replaced every seven days, or on a weekly basis. This schedule facilitates the replenishment of active viable cells and extracellular matrix (ECM) within the wound.

Given ActiGraft^Pro’s biological activity, it’s essential to monitor exudate levels closely and change the secondary dressing as necessary to avoid maceration or the buildup of excess exudate.